Jiang P, Ji S, Su D, Zhao Y, Goncalves VBE, Xu G, et al
These involved over 5,000 people who were either overweight or obese
Side effects are a manageable part of GLP-1 treatment, not a reason to avoid it or stop it prematurely
GLP-1 drugs may help by: Supporting weight loss Improving blood sugar control Lowering appetite and calorie intake Reducing strain linked with Excess body weight Improving some cardiometabolic markers Possibly affecting inflammation pathways Supporting better long-term risk management However, no patient should see these medicines as a quick fix
Every requirement has to match
Semaglutide is administered as a once-weekly subcutaneous injection (under the skin) in the stomach, thigh, or upper arm